Zheng YU

• Established a Singapore subsidiary and developed Asia-Pacific market entry strategies, including the engagement and management of local sales distributors. • Secured sales contracts exceeding RMB 2 million, cultivating enduring partnerships with multinational chemical industry leaders such as Evonik, Roehm Chemicals, and Chinese state-owned enterprises.

• Directed strategic business planning for a 5-year translational R&D Centre, securing Phase II funding from the government’s Innovation and Technology Commission (ITC). • Coached potential 9 spin-off companies, refining business plans, forging industry partnerships, and collaborating with incubators and investors. • Led negotiations to secure a term sheet for a spin-off start-up and facilitated NDAs and MoUs with numerous collaborators. • Pitching high-impact media and organizing media interviews with stories of raising awareness of CTSCB and the technologies

• Conducted market research with patients, doctors, and key opinion leaders, advising biotech clients on global product selection, registration, and clinical trial platforms. • Built and managed cross-border e-commerce platforms, overseeing trademark registration, logistics, and promotional campaigns.

• Pioneered strategic relationships with key clients, including China’s leading aesthetics company IMeik and dermatology pharmaceutical company Sinomune. • Led market research to inform product development strategies for semi-solid transdermal formulations. • Developed fundraising strategies, engaging private equity firms and government funds.

As the China Head of EDSEL Health Care, Identify new product registration strategy and agencies, search distribution partners, guide launch marketing strategies, and work with partners to ensure sales and logistics arrangements.

• Managed the new product launch assessment, products including oral care, ENT Rhinitis and Sinuses, Functional Health Food/Supplement, Nasal Care, and product extension for current topical analgesic portfolio, analysis, strategic planning and design. • Led the current business portfolio, the marketing strategies and executions, including Fastum topical analgesic gel, Dermatix scar reduction gel, Priligy for men’s health, and Ellgy Plus for footcare • Developed multi-channel integrated strategy, including HCP channel, retail channel, and e-commerce channels • Developed 5 year plan for Sales Force Effectiveness based on China retail development data/trend, including city priorities, sales manager and reps’ resourcing plan, and new product pipeline. • Developed sales KPI evaluation standard and tracking process (SOP), leverage e-platforms to manage data effectively, including KA contract, displays, trainings, enhancing visibility and availability, enabling team members' growth.

• Provided leadership for the consumer health division, overseeing the launch of new nail care products in China. This included the development and implementation of an integrated marketing campaign, encompassing both below-the-line (BTL) and above-the-line (ATL) executions, with a focus on enhancing marketing excellence. Market share for new products has increased from 0% to 20% over the first three months. • Developed and launched the TV commercial campaign for topical analgesics, in conjunction with Sports PR, store promotion and retail KA promotion. This initiative resulted in a 2.5-3 times growth within the first three launch years. • Collaborated with the regional office to organise the first Advisory Board meeting and establish strong relationships with key opinion leaders (KOLs). • Responsible of leading a team of product managers, key account sales managers and SFE training managers, developed the effective performance tracking systems.

• Oversaw the commercialisation of a cosmeceutical brand from the USA for Hollywood stars in seven Asian countries and regions, including Korea, Taiwan, Hong Kong, Thailand, the Philippines, Singapore and Malaysia, primarily via the prescription and recommendation of healthcare professionals for the repair and rejuvenation of skin following laser or injection procedures. • Collaborated with prominent dermatologists to organise the AP advisory board meeting and develop guidelines for post-laser-procedure skin care in the Asia-Pacific region. • Planned and conducted the largest clinical trial on Asian skin for aesthetic dermatology products. • Successfully rolled out the DTC online and offline consumer bloggerthon digital campaign across all markets. The CEO Silver Award is a prestigious accolade that recognises exceptional leadership and professional excellence.

• Led the successful launch of Mylanta, an anti-acid medication, managing advertising agencies for TV commercial creative development and investment. • Implemented disease awareness and healthcare education programs for patients, alongside distribution strategies, to drive sales growth post-launch.

Graduated with Second Major in International Business Administration